Amino acids in the saliva of patients with migraine

Headache

Volumn 39, Issue 9, 1999, Pages 644-649

  Rajda, C ^a   Tajti, J ^a   Komoroczy R ^b   Seres, E ^a   Klivenyi P ^a   Vécsei, László ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

^b Wheat and Triticale Breeder   (Hungary)

Author keywords

Amino acids; Migraine; Saliva

Indexed keywords

ARGININE; GLUTAMIC ACID; GLYCINE; ION CHANNEL; SERINE; TYROSINE;

ADULT; AMINO ACID ANALYSIS; ARTICLE; CENTRAL NERVOUS SYSTEM; CLINICAL ARTICLE; DOPAMINERGIC TRANSMISSION; ENERGY METABOLISM; FEMALE; HUMAN; MALE; MIGRAINE; NERVE EXCITABILITY; NEUROTRANSMITTER RELEASE; PATHOGENESIS; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SALIVA ANALYSIS;

EID: 0032739694     PISSN: 00178748     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1526-4610.1999.3909644.x     Document Type: Article

References (39)

1. Olesen J, Thomsen LL, Lassen LH, Olesen IJ. The nitric oxide hypothesis of migraine and other vascular headaches. Cephalalgia. 1995;15:94-100.
2. 2+ channel gene CACNL 1A4. Cell. 1996;87:543-552.
3. Uncini A, Lodi R, Di Muzio A, et al. Abnormal brain and muscle energy metabolism shown by 31P-MRS in familial hemiplegic migraine. J Neurol Sci. 1995;129:214-222.
4. Montagna P, Cortelli P, Monari L, et al. 31P-magnetic resonance spectroscopy in migraine without aura. Neurology. 1994;44:666-669.
5. D'Andrea G, Cananzi AR, Joseph R, et al. Platelet glycine, glutamate and aspartate in primary headache. Cephalalgia. 1991;11:197-200.
6. Cananzi AR, D'Andrea G, Perini F, Zamberlan F, Welch KM. Platelet and plasma levels of glutamate and glutamine in migraine with and without aura. Cephalalgia. 1995;15:132-135.
7. Ferrari MD, Odink J, Bos KD, Malessy MJ, Bruyn GW. Neuroexcitatory plasma amino acids are elevated in migraine. Neurology. 1990;40:1582-1586.
8. Marukawa H, Shimomura T, Takahashi K. Salivary substance P, 5-hydroxytryptamine, γ-aminobutyric acid levels in migraine and tension-type headache. Headache. 1996;36:100-104.
9. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia. 1988;8(suppl 7):1-96.
10. Navazesh M. Methods for collecting saliva. Ann N Y Acad Sci. 1993;694:72-77.
11. Bartók T, Szalai G, Lórincz ZS, Börcsök G, Sági F. High-speed RP-HPLC/FL analysis of amino acids after automated two-step derivatization with o-phthaldialdehyde/3-mercaptopropionic acid and 9-fluorenyl-methyl-chloroformate. J Liquid Chromatogr. 1994;17:4391-4403.
12. Brand HS, Jorning GG, Chamuleau RA, Abraham-Inpijn L. Effect of a protein-rich meal on urinary and salivary free amino acid concentrations in human subjects. Clin Chim Acta. 1997;264:37-47.
13. Goadsby PJ, Lance JW. Brain stem effects on intra-and extracerebral circulations. Relation to migraine and cluster headache. In: Olesen J, Edvinsson L, eds. Basic Mechanisms of Headache. New York: Elsevier Science Publishers; 1988:413-427.
14. Vécsei L, Tajti J, Szok D. Amines, purines, and aminoacids in tension-type headache and cluster headache. In: Olesen J, Edvinsson L, eds. Headache Pathogenesis: Monoamines, Neuropeptides, Purines and Nitric Oxide. Philadelphia: Lippincott-Raven Publishers; 1997:145-152.
15. Vécsei L, Widerlöv E, Ekman R, et al. Suboccipital cerebrospinal fluid and plasma concentrations of somatostatin, neuropeptide Y and beta-endorphin in patients with common migraine. Neuropeptides. 1992;22:111-116.
16. Kovács K, Kapócs G, Widerlöv E, Ekman R, Vécsei L, Jelencsik I, et al. Suboccipital cerebrospinal fluid and plasma concentrations of calcitonin gene-related peptide and corticotropin releasing hormone in patients with common migraine. Nord J Psykiatr. 1991;45:11-16.
17. Nicolodi M, Del Bianco E. Sensory neuropeptides (substance P, calcitonin gene-related peptide) and vasoactive intestinal polypeptide in human saliva: their pattern in migraine and cluster headache. Cephalalgia. 1990;10:39-50.
18. Welch KM, Barkley GL, Ramadan NM, D'Andrea G. NMR spectroscopic and magnetoencephalographic studies in migraine with aura: support for the spreading depression hypothesis. Pathol Biol (Paris). 1992;40:349-354.
19. D'Eufemia P, Finocchiaro R, Lendvai D, et al. Erythrocyte and plasma levels of glutamate and aspartate in children affected by migraine. Cephalalgia. 1997;17:652-657.
20. Schoenen J, Sianard-Gainko J, Lenaerts M. Blood magnesium levels in migraine. Cephalalgia. 1991; 11:97-99.
21. Gallai V, Sarchielli P, Coata G, Firenze C, Morucci P, Abbritti G. Serum and salivary magnesium levels in migraine. Results in a group of juvenile patients. Headache. 1992;32:132-135.
22. Sarchielli P, Coata G, Firenze C, Morucci P, Abbritti G, Gallai V. Serum and salivary magnesium levels in migraine and tension-type headache. Results in a group of adult patients. Cephalalgia. 1992;12:21-27.
23. Jain AC, Sethi NC, Babbar PK. A clinical electroen-cephalographic and trace element study with special reference to zinc, copper and magnesium in serum and cerebrospinal fluid (CSF) in cases of migraine. J Neurol. 1985;232(suppl):161.
24. Welch KM, Levine SR, D'Andrea G, Schultz LR, Helpern JA. Preliminary observations on brain energy metabolism in migraine studied by in vivo phosphorus 31 NMR spectroscopy. Neurology. 1989;39:538-541.
25. Ramadan NM, Halvorson H, Vande-Linde A, Levine SR, Helpern JA, Welch KM. Low brain magnesium in migraine. Headache. 1989;29:590-593.
26. Nowak L, Bregestovski P, Ascher P, Herbet A, Prochiantz A. Magnesium gates glutamate-activated channels in mouse central neurones. Nature. 1984;307:462-465.
27. Avoli M, Drapeau C, Louvel J, Pumain R, Olivier A, Villemure JG. Epileptiform activity induced by low extracellular magnesium in the human cortex maintained in vitro. Ann Neurol. 1991;30:589-596.
28. Mody I, Lambert JD, Heinemann U. Low extracellular magnesium induces epileptiform activity and spreading depression in rat hippocampal slices. J Neurophysiol. 1987;57:869-888.
29. Rothrock JF, Mar KR, Yaksh TL, Golbeck A, Moore AC. Cerebrospinal fluid analyses in migraine patients and controls. Cephalalgia. 1995;15:489-493.
30. Curran DA, Hinterberger H, Lance JW. Total plasma serotonin, 5-hydroxyindoleacetic acid and p-hydroxy-m-methoxymandelic acid excretion in normal and migrainous subjects. Brain. 1965;88:997-1010.
31. Somerville BW. Platelet-bound and free serotonin levels in jugular and forearm venous blood during migraine. Neurology. 1976;26:41-45.
32. Hilton BP, Cumings JN. 5-Hydroxytryptamine levels and platelet aggregation responses in subjects with acute migraine headache. J Neurol Neurosurg Psychiatry. 1972;35:505-509.
33. D'Andrea G, Toldo M, Cortelazzo S, Milone FF. Platelet activity in migraine. Headache. 1982;22:207-212.
34. Ferrari MD, Odink J, Tapparelli C, Van Kempen GM, Pennings EJ, Bruyn GW. Serotonin metabolism in migraine. Neurology. 1989;39:1239-1242.
35. 2 receptors. Cephalalgia. 1990;10:213-219.
36. Fozard JR. The 5-hydroxytryptamine-nitric oxide connection: the key link in the initiation of migraine? Arch Int Pharmacodyn Ther. 1995;329:111-119.
37. Gallai V, Floridi A, Mazzotta G, et al. L-arginine/nitric oxide pathway activation in platelets of migraine patients with and without aura. Acta Neurol Scand. 1996;94:151-160.
38. D'Andrea G, Cananzi AR, Perini F, et al. Decreased collagen-induced platelet aggregation and increased platelet arginine levels in migraine: a possible link with the NO pathway. Cephalalgia. 1994;14:352-356.
39. Castillo J, Martinez F, Suarez C, Naveiro J, Lema M, Noya M. Cerebrospinal fluid tyrosine and 3,4-dihydroxyphenylacetic acid levels in migraine patients. Cephalalgia. 1996;16:56-61.